Merck Announces Global Grants Program To Improve Access to Quality Health Care in Underserved Communities
- Merck's new grants program, Solutions for Healthy Communities (SHC), could positively impact the company's reputation and corporate social responsibility efforts. The investment in local strategies to meet health needs and priorities of underserved populations may enhance Merck's standing in the communities it operates in. The grants, ranging from $50,000 - $300,000, could also provide financial support to nonprofits, potentially fostering partnerships and goodwill for Merck.
- None.
RAHWAY, NJ / ACCESSWIRE / May 8, 2023 / To support the work of nonprofits dedicated to improving the well-being of underserved populations in communities around the world, Merck (NYSE:MRK), known as MSD outside of the United States and Canada, has announced a new global grants program, Solutions for Healthy Communities (SHC).
SHC will invest in strategies that are designed and led by local stakeholders to meet local health needs and priorities. Grants will cover two years of project implementation, and awards will range in size from
SHC aims to catalyze innovation and facilitate access to quality health care. The strategies that the program invests in should reach populations that are historically underserved by the health care system, including:
- Black, indigenous, and other people of color;
- People experiencing poverty;
- People living in rural areas;
- Migrant populations;
- People with diverse gender identities and/or sexual orientations;
- People living with disabilities.
SHC will be available in all of the regions in which the company operates, including the United States, Europe, the Middle East, Africa, Canada, Latin America and Asia Pacific, and the program will prioritize nonprofits that operate within 50 miles of a company site.
Apply here, if your organization is based in the United States. If your organization is not based in the United States, apply here. The deadline for applications is June 2, 2023.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world - and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company's Annual Report on Form 10-K for the year ended December 31, 2022 and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).
Learn more about Merck's Environmental, Social & Governance (ESG) approach by visiting merck.com/company-overview/esg.
View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.
Contact Info:
Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com
SOURCE: Merck & Co., Inc.
View source version on accesswire.com:
https://www.accesswire.com/753538/Merck-Announces-Global-Grants-Program-To-Improve-Access-to-Quality-Health-Care-in-Underserved-Communities
FAQ
What is Merck's new global grants program?
What is the range of grants offered by SHC?
Who is eligible to apply for SHC grants?
What is the deadline for SHC grant applications?
